Lederman Seth
Tonix Pharmaceuticals Holding Corp. · Chief Executive Officer
Lederman Seth is listed in public filings as director, officer: Chief Executive Officer. This Lederman Seth insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Tonix Pharmaceuticals Holding Corp. (TNXP). Investors use Lederman Seth's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $252k20k shares | BuyMar 31, 2026 | $63.1K5k shares | $12.62 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $223k15k shares | BuyMar 18, 2026 | $223.3K15k shares | $14.89 | -- | |
| $2.4M134.5k shares | Grant / ExerciseFeb 24, 2026 | $2.4M134.5k shares | $17.86 | -- | |
| $1.9M134.5k shares | Grant / ExerciseFeb 24, 2026 | $1.9M134.5k shares | $14.29 | -- | |
| $86k4k shares | BuyMay 15, 2025 | $86.2K4k shares | $21.55 | -- | |
| $1.2M124k shares | Grant / ExerciseFeb 25, 2025 | $1.2M124k shares | $10.06 | -- | |
| $998k124k shares | Grant / ExerciseFeb 25, 2025 | $997.9K124k shares | $8.05 | -- | |
| $175 shares | OtherFeb 5, 2025 | $185 shares | $3.38 | -- | |
| $31 shares | OtherFeb 5, 2025 | $1 | $3.30 | -- | |
| $01 shares | OtherFeb 5, 2025 | Disclosure amount unavailable1 shares | $0.15 | -- |